Molecular heterogeneity of β‐thalassaemia in a Spanish population from the area centre of Spain

Letters to the Editor P-Thalassaemia is a worldwide inherited disorder characterized by a reduction or complete absence of P-globin expression. The long frequency of thalassaemia is found in areas endemic for malaria, which includes the Mediterranean, Africa and Southeast Asia (1). More than 120 P-thalassaemia mutations have been described (2). However, each population group displays its own mutations. In the Mediterranean area more than 30 different mutations have been described, although only a few, generally 5, are responsible for almost 90% of the mutations. The incidence of heterozygous P-thalassaemia is high in Spain and may even reach 5% of the population in some regions (3-5). However, it does not constitute a serious public health problem as it is in some Mediterranean basin countries, such as Italy and Greece (6,7), since less than 70 cases of homozygote P-thalassaemia have been recorded in Spain. Spain is a geographic area whose racial characteristics have been formed by emigration, over the centuries, from numerous people that colonized the Iberian Peninsula. The Moslem occupation of the Iberian Peninsula, which took place in AD 713, continued until 1492. After that, the population movements were scant except for those produced in the last century by the internal shifting of the Spanish inhabitans from village settlements to the industrial nucleus of large industrial areas in cities. Molecular studies carried out in the Spanish population have manifested that the mutations correspond to those previously described in other countries of the Mediterranean basin (4, 6, 8). In this study a total of 134 alleles relating to 131 patients from Madrid, Castilla la Mancha and Castilla y Le6n has been studied; of them, 9 had P-thalassaemia major (12 alleles, since there were 3 pairs of brothers) and 122 unrelated patients the P-thalassaemia trait. Blood samples were collected in EDTA. Most of these (122 patients) were heterozygous Pthalassaemia with mild anaemia, microcytosis and hypochromia and elevated levels of Hb A,, and 9 eitv of 13 I onhorn l-tha the lassa area .e rnia

[1]  P. Extermann,et al.  Prevention of beta-thalassemia major and Hb Bart's hydrops fetalis syndrome. , 1995, Seminars in hematology.

[2]  S. Thein 6 β-Thalassaemia , 1993 .

[3]  D. Weatherall,et al.  Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK , 1990, The Lancet.

[4]  H. Kazazian The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. , 1990, Seminars in hematology.

[5]  C Summers,et al.  Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). , 1989, Nucleic acids research.

[6]  X. Estivill,et al.  Determination of the spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of amplified beta-globin DNA. , 1988, American journal of human genetics.

[7]  M. Pirastu,et al.  β-thalassemia mutations in the Portuguese population , 2004, Human Genetics.

[8]  S. De Virgiliis,et al.  Clinical experience of management of thalassemia: the Sardinian experience. , 1996, Seminars in hematology.

[9]  D. Loukopoulos Current status of thalassemia and the sickle cell syndromes in Greece. , 1996, Seminars in hematology.

[10]  Ana B Enito,et al.  Beta-thalassaemia in south-western Spain: high frequency of G-->A (IVS I-1) mutation. , 1996 .

[11]  E. del Potro,et al.  Hematologic data in 825 cases of beta-thalassemia trait in Spain. , 1990, Nouvelle revue francaise d'hematologie.

[12]  S. Surrey,et al.  Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. , 1982, Hemoglobin.